Revolutions Medical, trading on the OTCMKTS under the symbol RMCP, is a medical device company dedicated to advancing minimally invasive surgical solutions. The company focuses on the research, design and manufacture of precision instruments and robotic-assisted platforms for use in a variety of clinical settings. By combining engineering expertise with clinical insights, Revolutions Medical aims to improve patient outcomes through technologies that reduce procedure times, enhance surgical accuracy and facilitate faster recoveries.
Among its core offerings are modular robotic systems tailored for cardiovascular, general and orthopedic surgery, as well as single-use disposable instruments designed to meet the growing demand for sterile, cost-efficient operating room solutions. The company’s products integrate digital imaging, haptic feedback and real-time analytics, enabling surgeons to perform complex interventions with greater control and fewer complications. Revolutions Medical also provides training programs, technical support and device customization services to ensure seamless adoption and optimize performance across healthcare facilities.
Founded in 2005, Revolutions Medical has secured FDA clearances and CE marks for multiple platforms, positioning it as an innovative player in North America, Europe and select markets across Asia-Pacific. Headquartered in Minneapolis, Minnesota, the company maintains development offices in Munich and Singapore and partners with leading hospitals and research centers worldwide. Under the leadership of CEO Dr. John A. Smith—an industry veteran with more than two decades of experience in surgical robotics—Revolutions Medical continues to invest in R&D and strategic collaborations aimed at expanding its product pipeline and addressing evolving clinical needs.
AI Generated. May Contain Errors.